Kartufan Fatma Ferda, Kizilcik Nurcan, Ziylan Sule, Menda Ferdi
Department of Anesthesia and Reanimation, Hospital of Medistanbul, Istanbul, Turkey.
Department of Anesthesia and Reanimation, Faculty of Medicine, Yeditepe University, Istanbul, Turkey.
J Ophthalmol. 2022 Sep 21;2022:4137144. doi: 10.1155/2022/4137144. eCollection 2022.
In this single-blind, observational prospective clinical trial, we aimed to determine and compare the effects of premedication with hydroxyzine plus midazolam and midazolam alone on the incidence of oculocardiac reflex (OCR).
Forty-five patients were divided into three groups. Group M received 0.5 mg/kg midazolam alone, Group H received 0.5 mg/kg hydroxyzine plus 0.5 mg/kg midazolam, and Group HM received 1 mg/kg hydroxyzine plus 0.5 mg/kg midazolam. The Ramsay Sedation Scale (RSS), the heart rates (HR1: after induction of anesthesia; HR2: before retraction of orbital muscle; and HR3: right after retraction of orbital muscle), the muscles with OCR, and the incidence of OCR (20% decrease of the HR right after the traction) were recorded and compared between the three groups.
The mean HR1, HR2, and HR3 values were significantly increased (=0.002, < 0.001, < 0.001) and the incidence of OCR (=0.004) was significantly decreased in Group H and in Group HM (for all, < 0.01) compared to Group M. The most common orbital muscle in which OCR occurred was the rectus medialis.
Premedication with a combination of 0.5 or 1 mg hydroxyzine with 0.5 mg midazolam significantly reduced the incidence of OCR compared to premedication with midazolam alone. This study was registered on https://clinicaltrials.gov/ with number NCT03806270.
在这项单盲、观察性前瞻性临床试验中,我们旨在确定并比较羟嗪加咪达唑仑与单独使用咪达唑仑进行术前用药对眼心反射(OCR)发生率的影响。
45例患者被分为三组。M组单独接受0.5mg/kg咪达唑仑,H组接受0.5mg/kg羟嗪加0.5mg/kg咪达唑仑,HM组接受1mg/kg羟嗪加0.5mg/kg咪达唑仑。记录并比较三组的 Ramsay 镇静评分(RSS)、心率(HR1:麻醉诱导后;HR2:眶肌牵拉前;HR3:眶肌牵拉后即刻)、发生OCR的肌肉以及OCR发生率(牵拉后心率即刻下降20%)。
与M组相比,H组和HM组的平均HR1、HR2和HR3值显著升高(=0.002,<0.001,<0.001),OCR发生率(=0.004)显著降低(均<0.01)。发生OCR最常见的眶肌是内直肌。
与单独使用咪达唑仑进行术前用药相比,0.5或1mg羟嗪与0.5mg咪达唑仑联合进行术前用药可显著降低OCR发生率。本研究已在https://clinicaltrials.gov/上注册,注册号为NCT03806270。